Etodolac and Ribavirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Ribavirin (ribavirin). Common drug interactions include haemorrhoids among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Ribavirin. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.



On Jul, 10, 2026

35 people who take Etodolac and Ribavirin together, and have interactions are studied.

Etodolac and Ribavirin drug interactions.

What are the common drug interactions of Etodolac and Ribavirin, by gender? *:

female:

  1. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  2. Headache (pain in head)
  3. Injection site reaction
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Ocular hyperaemia (an abnormally large amount of blood in eye)
  6. Oropharyngeal pain
  7. Overdose
  8. Petit mal epilepsy (absence seizure)
  9. Proctalgia (pain in the rectum)
  10. Pruritus (severe itching of the skin)

male:

  1. Haemoglobin decreased
  2. White blood cell count decreased
  3. Decreased appetite
  4. Asthma
  5. Dysuria (painful or difficult urination)
  6. Erythema multiforme (a type of hypersensitivity reaction)
  7. Heart injury
  8. Loss of consciousness
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Micturition urgency (urgency to pass the urine)

What are the common drug interactions of Etodolac and Ribavirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Weight decreased
  2. Asthenia (weakness)
  3. Asthma
  4. Heart injury
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Adverse event
  8. Alopecia (absence of hair from areas of the body)
  9. Blood cholesterol increased
  10. Cardiac disorder

40-49:

  1. Haemoglobin decreased
  2. White blood cell count decreased
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Dysuria (painful or difficult urination)
  7. Micturition urgency (urgency to pass the urine)
  8. Nausea (feeling of having an urge to vomit)
  9. Nocturia (the need to get up in the night to urinate)
  10. Renal pain (kidney pain)

50-59:

  1. Anaemia (lack of blood)
  2. Erythema multiforme (a type of hypersensitivity reaction)
  3. Haemoglobin decreased
  4. Loss of consciousness
  5. White blood cell count decreased
  6. Decreased appetite
  7. Rash
  8. Gastric ulcer (stomach ulcer)
  9. Alopecia (absence of hair from areas of the body)
  10. Anorectal discomfort

60+:

  1. Blood bilirubin increased
  2. Haemoglobin decreased
  3. Chills (felling of cold)
  4. Diarrhoea
  5. Erysipelas (bacterial skin infection)
  6. Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
  7. Injection site erythema (redness at injection site)
  8. Melaena (the passage of black, tarry stools)
  9. Nausea (feeling of having an urge to vomit)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the existing conditions these people have? *

  1. Pain: 7 people, 20.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 20.00%
  3. Stress And Anxiety: 6 people, 17.14%
  4. Muscle Spasms (muscle contraction): 5 people, 14.29%
  5. Leukocytosis (increased white blood cells): 5 people, 14.29%
  6. Iron Deficiency Anaemia: 5 people, 14.29%
  7. Insomnia (sleeplessness): 3 people, 8.57%
  8. Hypersensitivity: 3 people, 8.57%
  9. Depression: 3 people, 8.57%
  10. Muscle Aches (muscle pain): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Ribavirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Etodolac and Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etodolac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etodolac and ribavirin (the active ingredients of Etodolac and Ribavirin, respectively), and Etodolac and Ribavirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: